Pulmonary microvascular endothelial cell junction

Pulmonary microvascular endothelial cell junctions are specialized structures that form at the interfaces between adjacent pulmonary microvascular endothelial cells. They serve as key regulators of vascular permeability and barrier function within the lung’s microvasculature, controlling the movement of fluids, solutes, leukocytes, and macromolecules between the blood and lung tissues[1][2][3][4][5]. These junctions are composed of tight junctions, adherens junctions, and to a lesser extent, gap junctions, each formed by a network of molecules such as VE-cadherin, N-cadherin, ALCAM, ESAM, and others[1][2][3]. Their structural and functional integrity is essential for maintaining pulmonary vascular homeostasis and preventing pathological leakage or infiltration during disease states such as inflammation, acute lung injury, and infection[4][5]. Although often referenced in basic and translational research related to the vascular barrier, the junction itself is not a discrete drug target or molecule, but rather a collective term describing the sum of adhesive interactions and protein complexes at the lateral borders of lung microvascular endothelial cells[1][4][3]. Clarification: "Pulmonary microvascular endothelial cell junctions" refers to a cellular structure, not an individual molecule, protein, receptor, or classical drug target, but rather a complex of multiple adhesion molecules and signaling proteins that together mediate endothelial barrier function in the lung microvasculature. Therefore, it is not a single therapeutic target but a structural and functional ensemble, and entries for abbreviation, interacting drugs, mechanisms, or biomarkers should be considered null or not applicable in structured databases.

Other names

Lung microvascular endothelial cell junctionMicrovascular endothelial cell-cell junction (lung)Pulmonary microvascular endothelial junction